Scribd Logo
Fazer o upload

Bem-vindo(a) ao Scribd!

  • T1DF Letter To EpiPen MDL Judge Crabtree Re Intra Class Conflicts

    Enviado por

    The Type 1 Diabetes Defense Foundation
    24 visualizações6 páginas
    T1DF's three diabetes product cases addressed a rebate-pumping and rebate-capture scheme (by payors, health plans and the U.S. Office of Personnel Management in FEHBP) that similarly drove up list prices for EpiPen kits (list prices of EpiPen kits, analog insulins, glucagon kits and test strips are similarly heavily rebated by their manufacturers). These cases document the intra-class conflict between the two sub-classes of the EpiPen MDL National Class--3rd-party payers/insurers and patients.

    Título original

    T1DF Letter to EpiPen MDL Judge Crabtree re Intra Class Conflicts

    Direitos autorais

    © Attribution Non-Commercial No-Derivs (BY-NC-ND)

    Formatos disponíveis

    PDF, TXT ou leia online no Scribd

    Você considera este documento útil?

    Este conteúdo é inapropriado?

    Denunciar este documento
    T1DF's three diabetes product cases addressed a rebate-pumping and rebate-capture scheme (by payors, health plans and the U.S. Office of Personnel Management in FEHBP) that similarly drove up list prices for EpiPen kits (list prices of EpiPen kits, analog insulins, glucagon kits and test strips are similarly heavily rebated by their manufacturers). These cases document the intra-class conflict between the two sub-classes of the EpiPen MDL National Class--3rd-party payers/insurers and patients.

    Direitos autorais:

    Attribution Non-Commercial No-Derivs (BY-NC-ND)
    Baixe no formato PDF, TXT ou leia online no Scribd
    Sinalizar o conteúdo como inadequado
    24 visualizações6 páginas

    T1DF Letter To EpiPen MDL Judge Crabtree Re Intra Class Conflicts

    Enviado por

    The Type 1 Diabetes Defense Foundation
    T1DF's three diabetes product cases addressed a rebate-pumping and rebate-capture scheme (by payors, health plans and the U.S. Office of Personnel Management in FEHBP) that similarly drove up list prices for EpiPen kits (list prices of EpiPen kits, analog insulins, glucagon kits and test strips are similarly heavily rebated by their manufacturers). These cases document the intra-class conflict between the two sub-classes of the EpiPen MDL National Class--3rd-party payers/insurers and patients.

    Direitos autorais:

    Attribution Non-Commercial No-Derivs (BY-NC-ND)
    Baixe no formato PDF, TXT ou leia online no Scribd
    Sinalizar o conteúdo como inadequado
    de 6

    Case 2:17-md-02785-DDC-TJJ Document 1573-1 Filed 05/13/19 Page 2 of 7

    Case 2:17-md-02785-DDC-TJJ Document 1573-1 Filed 05/13/19 Page 3 of 7


    Case 2:17-md-02785-DDC-TJJ Document 1573-1 Filed 05/13/19 Page 4 of 7
    Case 2:17-md-02785-DDC-TJJ Document 1573-1 Filed 05/13/19 Page 5 of 7
    Case 2:17-md-02785-DDC-TJJ Document 1573-1 Filed 05/13/19 Page 6 of 7
    Case 2:17-md-02785-DDC-TJJ Document 1573-1 Filed 05/13/19 Page 7 of 7

    Você também pode gostar